Picture of VentriPoint Diagnostics logo

VPT VentriPoint Diagnostics Share Price

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Momentum

Relative Strength (%)
1m-25.66%
3m-24.18%
6m+1.05%
1yr-2.84%
Volume Change (%)
10d/3m-45.37%
Price vs... (%)
52w High-36.11%
50d MA-15.9%
200d MA-0.97%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value27.51
Price to Tang. Book27.51
Price to Free Cashflown/a
Price to Sales1,007.3
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-294.62%
Return on Equity-141.63%
Operating Margin-13380.83%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of VentriPoint Diagnostics EPS forecast chart

Profile Summary

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

Directors

Last Annual
December 31st, 2022
Last Interim
September 30th, 2023
Incorporated
September 18th, 2007
Public Since
November 9th, 2005
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
ca flag iconTSX Venture Exchange
Shares in Issue
157,182,655

VPT Share Price Performance

Upcoming Events for VPT

Q4 2023 VentriPoint Diagnostics Ltd Earnings Release

Q1 2024 VentriPoint Diagnostics Ltd Earnings Release

Q2 2024 VentriPoint Diagnostics Ltd Earnings Release

Similar to VPT

Picture of Aurora Spine logo

Aurora Spine

ca flag iconTSX Venture Exchange

Picture of CardioComm Solutions logo

CardioComm Solutions

ca flag iconTSX Venture Exchange

Picture of Cloud DX logo

Cloud DX

ca flag iconTSX Venture Exchange

Picture of Enablence Technologies logo

Enablence Technologies

ca flag iconTSX Venture Exchange

Picture of EvokAI Creative Labs logo

EvokAI Creative Labs

ca flag iconTSX Venture Exchange

FAQ